Lincoln Pharmaceuticals enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


1,118	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
266	230	187	145	96.4
4.4	4.4	0.0	1.1	2.0
856	—	—	—	—
−261	−226	−187	−144	−94.4
₹427.57	—	—	—	—

816	762	672	594	504
0.5%	0.6%	0.0%	0.2%	0.4%
0.01×	—	—	—	—

1.19×	—	—	—	—
8.60×	—	—	—	—
10.15×	—	—	—	—
10.66×	—	—	—	—
722	671	623	581	510
99.6	97.7	101	99.9	89.2
84.4	83.2	88.6	89.3	80.0
—	106	93.0	63.2	39.3
80.3	80.3	74.0	23.7	25.0
—	80.1	73.5	23.4	24.4
—	26.0	19.0	39.5	14.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LINCOLN₹558.10

Lincoln Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersSIGACHI THEMISMED BAJAJHCARE AMRUTANJANJAGSNPHARM WANBURY AHCLMcap ₹1,118 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	1,117.9
- Cash, Equiv & ST Investments	96.4	144.7	187.1	230.1	265.9
+ Total Debt	2.0	1.1	0.0	4.4	4.4
Enterprise Value	—	—	—	—	856.4
Net Debt (memo)	-94.4	-143.6	-187.1	-225.6	-261.4
EV per Share	—	—	—	—	427.57

Total Capital	504.5	593.9	671.7	762.1	815.9
Total Debt/Total Capital	0.40	0.18	0.00	0.58	0.54
Total Debt/EV	—	—	—	—	0.01

EV/Sales	—	—	—	—	1.19
EV/EBITDA	—	—	—	—	8.60
EV/EBIT	—	—	—	—	10.15
EV/Free Cash Flow	—	—	—	—	10.66
Reference Items — Trailing FY Values
Sales	510.3	580.5	623.2	671.0	722.2
EBITDA	89.2	99.9	101.5	97.7	99.6
EBIT	80.0	89.3	88.6	83.2	84.4
Operating Cash Flow	39.3	63.2	93.0	106.4	—
Free Cash Flow	25.0	23.7	74.0	80.3	80.3
FCFF (free cash flow to the firm)	24.4	23.4	73.5	80.1	—
Capital Expenditure	14.3	39.5	19.0	26.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.